U.S. markets open in 2 hours 57 minutes

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.39+1.92 (+5.41%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close35.47
Open35.60
Bid0.00 x 900
Ask0.00 x 900
Day's Range35.13 - 38.35
52 Week Range22.01 - 47.48
Volume149,374
Avg. Volume117,666
Market Cap531.48M
Beta (5Y Monthly)1.20
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateMar 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est52.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-17% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021
    GlobeNewswire

    Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021

    BEDFORD, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, today announced that the Company plans to issue its fourth quarter and year-end 2020 financial results after the close of the market on Thursday, March 4, 2021 and hold its investor conference call and webcast on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-855-327-6837 (toll-free domestic) or 1-631-891-4304 (international) and providing the conference ID number 10012940. A live audio webcast will be available in the "Investor Relations" section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika investor relations website. The call will be archived and accessible on the same website shortly after its conclusion. About Anika Therapeutics, Inc. Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com. For Investor Inquiries:Anika Therapeutics, Inc.Mark Namaroff, 781-457-9287Executive Director, Investor Relations and Corporate Communicationsinvestorrelations@anika.com

  • Keep These 4 Toxic Stocks Away From Your Portfolio
    Zacks

    Keep These 4 Toxic Stocks Away From Your Portfolio

    Just like selecting good and undervalued stocks on a regular basis can make you rich, identifying and proactively getting rid of toxic stocks is also crucial to maximizing portfolio returns.

  • An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 28% Undervalued
    Simply Wall St.

    An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 28% Undervalued

    Today we will run through one way of estimating the intrinsic value of Anika Therapeutics, Inc. ( NASDAQ:ANIK ) by...